New Nordic Healthbrands AB (publ)
New Nordic Healthbrands AB (publ) develops and markets dietary supplements, herbal pharmaceutical, and personal care products in the Nordic countries, rest of Europe, North America, and internationally. The company provides vitality tablets, capsules, and gummy products, including vitamins and minerals, fish oil and Omega-3, and magnesium, as well as for body, sleep and relaxation, menopause, and… Read more
New Nordic Healthbrands AB (publ) (NNH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.025x
Based on the latest financial reports, New Nordic Healthbrands AB (publ) (NNH) has a cash flow conversion efficiency ratio of 0.025x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr2.60 Million) by net assets (Skr102.47 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
New Nordic Healthbrands AB (publ) - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how New Nordic Healthbrands AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
New Nordic Healthbrands AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of New Nordic Healthbrands AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Love Group Global Ltd
AU:LVE
|
0.299x |
|
SWISS RE N (SR9.SG)
STU:SR9
|
0.000x |
|
CDTi Advanced Materials Inc
PINK:CDTI
|
-0.181x |
|
Searchlight Minerals Corp
PINK:SRCH
|
-0.007x |
|
LEGRAND (LRC.SG)
STU:LRC
|
-0.080x |
|
Green Minerals AS
OL:GEM
|
0.001x |
|
Asdion Bhd
KLSE:0068
|
60.174x |
|
Inhalerx Ltd
AU:IRX
|
-0.044x |
Annual Cash Flow Conversion Efficiency for New Nordic Healthbrands AB (publ) (2008–2024)
The table below shows the annual cash flow conversion efficiency of New Nordic Healthbrands AB (publ) from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr100.53 Million | Skr-5.40 Million | -0.054x | -120.32% |
| 2023-12-31 | Skr106.03 Million | Skr28.03 Million | 0.264x | +292.58% |
| 2022-12-31 | Skr112.57 Million | Skr-15.45 Million | -0.137x | -109.83% |
| 2021-12-31 | Skr120.32 Million | Skr-7.87 Million | -0.065x | -134.84% |
| 2020-12-31 | Skr104.81 Million | Skr19.68 Million | 0.188x | +2969.14% |
| 2019-12-31 | Skr101.92 Million | Skr-667.00K | -0.007x | -102.94% |
| 2018-12-31 | Skr80.21 Million | Skr17.85 Million | 0.223x | -48.77% |
| 2017-12-31 | Skr60.81 Million | Skr26.42 Million | 0.434x | +1049.82% |
| 2016-12-31 | Skr42.98 Million | Skr1.62 Million | 0.038x | +152.80% |
| 2015-12-31 | Skr35.77 Million | Skr-2.56 Million | -0.072x | -155.97% |
| 2014-12-31 | Skr25.06 Million | Skr3.20 Million | 0.128x | +258.66% |
| 2013-12-31 | Skr13.55 Million | Skr483.00K | 0.036x | -92.75% |
| 2012-12-31 | Skr8.47 Million | Skr4.17 Million | 0.492x | +553.75% |
| 2011-12-31 | Skr11.63 Million | Skr875.00K | 0.075x | -57.52% |
| 2010-12-31 | Skr11.43 Million | Skr2.02 Million | 0.177x | -74.70% |
| 2009-12-31 | Skr14.82 Million | Skr10.37 Million | 0.700x | +30.64% |
| 2008-12-31 | Skr9.07 Million | Skr4.86 Million | 0.536x | -- |